Connect with us

Latest News

Flipkart Pulls Of One OF The Biggest Employee Retention Coups Yet!

Published

on

Flipkart Biggest Employee Retention Coups,Biggest Employee Retention In e commerce,Best Retention Strategies Used By Flipkart,Flipkart New Plan Employee Retention,employee retention scheme,Startup Stories,Latest Business News 2017,Inspirational Stories 2017

Earlier in the year, Flipkart issued a statement it would issue stock options for all its eligible employees under a stock option plan to prevent them from being affected by the share price drop during their latest fundraiser. Thousands of Flipkart employees received shares of stocks under this scheme. The people who were eligible for this particular plan were those who were issued shares after the recent revaluation. Flipkart created this new scheme in an attempt to make a big impact in their end financial game plan.

The new plan by Flipkart is considered to be one of the biggest buyback plans that has been approved by a capital venture. Through the new plan, the board of Flipkart made sure that they can help about 6000 former and current employees. This is one of the biggest incentives by the company to help these employees to liquidate their share holdings in Flipkart.

The move came at a time when Flipkart realized most of its spending was on salaries. In order to reduce this expenditure, Flipkart decided to give 35% to 40% of its mid level to senior level employees stock values rather than to pay them the entire salary. This bid has also been launched in an attempt to retain employees with exceptional talents and value adding capabilities.

In a bid to create a greater employee retention scheme, Flipkart is aiming at creating a unified employee and employer relationship, making working a unique and fun experience.

Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Shein’s India Comeback: A Strategic Partnership with Reliance

Published

on

Shein returns in India with the alliance of reliance.

Shein, the popular Chinese fast-fashion retailer, is set to make a return to the Indian market, but with a significant twist. After being banned in 2020 due to data privacy concerns, Shein has partnered with Indian retail giant Reliance to circumvent these restrictions. This strategic move will allow the brand to continue its operations in India while adhering to the country’s strict data localization laws.

Key Points of the Agreement

  • Data Localization: As part of the agreement, Shein will relinquish control of its local operations and data to Reliance Retail. All data collected from Indian customers will be stored within India, ensuring compliance with local regulations and addressing national security concerns.
  • Reliance as the Platform Owner: Reliance Retail will own and operate the platform, maintaining complete control over the technology and infrastructure. This arrangement allows Shein to operate purely as a technology partner without direct involvement in local operations.
  • Local Manufacturing: Shein will collaborate with Indian manufacturers to produce products under its brand name. This initiative aims to boost the local textile industry and create jobs by establishing a network of manufacturers capable of meeting both domestic and international demand.
  • Strict Security Measures: Both parties will adhere to stringent security measures to safeguard user data and comply with Indian laws. This includes regular security audits conducted by government-empaneled cybersecurity auditors.

Background on Shein’s Ban and Return

Shein was among over 300 Chinese apps banned in India in mid-2020 due to rising national security concerns following border tensions between India and China. The Indian government cited issues related to digital sovereignty as the primary reason for the ban. Although Shein’s app was removed from Indian app stores, its products continued to be available through other platforms like Amazon.

With this new partnership, Reliance aims to leverage its extensive retail infrastructure while enabling Shein to re-enter the market under a framework that satisfies regulatory requirements.

Economic Impact and Future Prospects

The partnership not only allows Shein to re-enter the Indian market but also positions it to tap into India’s growing consumer base. According to recent reports, the fast fashion market in India is projected to surpass $50 billion by FY31, outpacing other retail sectors.

Shein plans to provide training and support to over 25,000 local suppliers, integrating them into its global supply chain. By sourcing products locally, Shein aims to reduce its dependence on Chinese manufacturing while boosting India’s textile exports.

Competitive Landscape

The collaboration between Shein and Reliance is expected to shake up the Indian fast fashion market, which has seen competitors like Urbanic, Romwe, and Zudio attempt to fill the gap left by Shein’s absence. With Reliance’s significant market presence and resources, this partnership could redefine competition in the sector.

Conclusion

By partnering with Reliance, Shein aims to mitigate risks associated with data privacy and national security concerns while re-establishing its brand in India. This strategic move not only allows for compliance with local regulations but also supports India’s push for self-reliance in manufacturing and economic growth. However, it remains to be seen how consumers will react to this new model and whether it will be successful in the long run. As Shein prepares for its comeback, all eyes will be on how it navigates this complex landscape while appealing to Indian consumers once again.

Continue Reading

Latest News

Athera Venture Partners Secures Major Investment from HDFC AMC

Published

on

Athera-ventures-partners-with-HDFC-AMC-for-the-funding

Athera Venture Partners, a prominent tech-focused venture capital firm, has successfully secured a substantial investment from HDFC Asset Management Company (AMC’s) Select AIF FoF I Scheme for its upcoming Fund IV. This strategic move strengthens Athera’s position as a leading investor in India’s burgeoning startup ecosystem.

Key Highlights

  • Significant Investment: HDFC AMC’s investment will play a major role in Athera’s Fund IV, which is targeting a corpus of ₹900 crore (approximately $108 million). This funding will enable Athera to expand its portfolio and support emerging startups.
  • Focus on Tech-Driven Startups: Athera will continue to invest in promising startups operating in sectors such as Consumer Internet, Enterprise Software, Artificial Intelligence (AI), and other emerging technologies. The firm aims to identify and nurture innovative companies that have the potential to disrupt traditional industries.
  • Strong Investment Track Record: Athera has a proven history of backing successful startups, including notable names like redBus, PolicyBazaar, and Pixxel. This track record demonstrates the firm’s ability to identify high-potential ventures and provide them with the necessary resources for growth.
  • Founder-First Approach: Athera is committed to supporting ambitious founders by providing them with the necessary resources and mentorship to scale their businesses effectively. This founder-centric philosophy is central to Athera’s investment strategy.

Athera’s Vision for the Future

With the backing of HDFC AMC, Athera is well-positioned to capitalize on India’s growing startup ecosystem. The firm aims to identify and nurture the next generation of innovative companies that can create significant value across various sectors.

By providing strategic guidance, capital, and operational expertise, Athera empowers entrepreneurs to build sustainable and scalable businesses. The firm’s long-term commitment to its portfolio companies and its strong network of industry leaders contribute to its success.

Recent Developments

Athera Venture Partners recently launched its Fund IV following a rebranding from Inventus Capital in May 2022. The firm has already backed six startups through this fund, including:

  • Clickpost: A logistics platform.
  • CynLr: A robotics startup.
  • Ati Motors: An autonomous electric vehicle manufacturer.
  • Terra: A gaming firm.
  • Hyprbots: An AI finance startup.
  • Billion Hearts: A consumer tech startup founded by Koo co-founder Mayank Bidwatka.

The fund focuses on seed and Series A deals, looking to invest between ₹5 crore to ₹25 crore in 16 to 18 companies over the next 18 to 24 months.

Conclusion

The collaboration between Athera Venture Partners and HDFC AMC underscores the growing trend of domestic capital flowing into India’s venture capital space. As more local investors recognize the potential of homegrown startups, firms like Athera are poised to play a critical role in fostering innovation and driving economic growth in India. With a strong investment strategy focused on technology-driven sectors and a commitment to supporting founders, Athera Venture Partners is well-equipped to navigate the evolving landscape of the Indian startup ecosystem.

Continue Reading

Latest News

Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!

Published

on

Infosys Invests in 4baseCare to Boost Healthcare Tech Offerings!

Infosys, a global leader in next-generation digital services and consulting, has announced a strategic investment of INR 8.3 crore (approximately $1 million) in 4baseCare, a promising healthcare deep-tech firm specializing in precision oncology solutions. This investment underscores Infosys’ commitment to leveraging cutting-edge technologies to address critical healthcare challenges.

About 4baseCare

Founded in 2018 by Hitesh Goswami and Kshitij Rishi, 4baseCare focuses on utilizing advanced genomics and clinical data to personalize cancer treatment. The firm employs AI and analytics to improve cancer diagnosis, treatment, and drug discovery. Their unique approach includes the development of comprehensive genomic panels that enable oncologists to select optimal targeted therapies for patients.

Precision Oncology Solutions

4baseCare’s precision oncology solutions are designed to:

  • Enhance Cancer Diagnosis: By integrating diverse genomic data, the platform allows for more accurate identification of cancer types and stages.
  • Personalize Treatment Plans: Utilizing AI-driven insights, the startup aims to tailor treatment strategies based on individual patient profiles.
  • Accelerate Drug Discovery: The data-driven approach helps streamline the development of new cancer therapies.

Strategic Alignment with Infosys

Infosys’ investment in 4baseCare aligns with its broader strategy to foster innovation and drive digital transformation within the healthcare industry. By partnering with 4baseCare, Infosys aims to enhance its offerings and provide advanced solutions to its clients in the healthcare and life sciences sectors.

Expected Benefits of the Investment

The investment will enable Infosys to tap into 4baseCare’s expertise in precision oncology, allowing it to:

  • Develop innovative healthcare solutions that can improve patient outcomes.
  • Leverage advanced analytics to reduce healthcare costs through more effective treatments.
  • Enhance its portfolio of services aimed at healthcare providers and institutions.

Future Prospects

This strategic move comes at a time when the Indian healthtech startup ecosystem is gaining momentum. Despite facing challenges in fundraising—having raised only $7 billion across 886 deals from 2014 to mid-2024—the sector is witnessing increased interest from investors seeking innovative solutions to pressing healthcare issues.

In recent months, 4baseCare has also made headlines by raising $6 million in its Series A funding round led by Yali Capital, demonstrating strong investor confidence in its potential.

Conclusion

Infosys’ investment in 4baseCare represents a significant step toward enhancing its capabilities in the healthcare sector, particularly in precision oncology. By combining Infosys’ technological prowess with 4baseCare’s innovative solutions, this partnership is poised to make a meaningful impact on cancer treatment and patient care. As both companies work together to advance healthcare technology, they are likely to contribute significantly to improving health outcomes and driving efficiencies within the industry.

Continue Reading
Advertisement

Recent Posts

Advertisement